Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Dec, 18 2025
Oct, 10 2025
May, 11 2025
Dec, 19 2025
Feb, 7 2025